Paris, France and Camberley, UK – 12 November 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it has been notified that, on
Novacyt S.A. (NCYT.L) Liquidity Agreement and Total Voting Rights
Paris, France and Camberley, UK – 2 November 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its monthly update in relation to ordinary
Novacyt S.A. (NCYT.L) Acquisition of IT-IS International Ltd
Deal in line with strategy, secures key IP for the Company’s rapid-PCR instruments, expands its core capabilities and product offering
Novacyt S.A. (NCYT.L) Launch of COVID-19 antibody test
Paris, France and Camberley, UK – 29 September 2020 – Novacyt, an international specialist in clinical diagnostics, announces that, further to the announcement on 27 July 2020, the Company has
Novacyt S.A. (NCYT.L) Launch of two gene COVID-19 test
Paris, France and Camberley, UK – 4 September 2020 – Novacyt ( EURONEXT GROWTH: ALNOV; AIM: NCYT ), an international specialist in clinical diagnostics, announces that, further to the announcement
Novacyt S.A. (NCYT.L) Launch of respiratory test panel
New test differentiates COVID-19 from common winter diseases
Novacyt S.A. (NCYT.L) Significant new opportunities for growth
Paris, France and Camberley, UK – 27 July 2020 – Novacyt ( EURONEXT GROWTH: ALNOV; AIM: NCYT ), an international specialist in clinical diagnostics, announces an R&D update.
Novacyt S.A. (NCYT.L) Sales and regulatory update
Paris, France and Camberley, UK – 2 June 2020 – Novacyt ( EURONEXT GROWTH: ALNOV; AIM: NCYT ), an international specialist in clinical diagnostics, provides an update on its polymerase